Clinical Neurology NewsSwitching RRMS patients to daclizumab beta appears safeFebruary 3, 2018Multiple Sclerosis
Clinical Neurology NewsVIDEO: Oral ozanimod shows promise for relapsing MSFebruary 3, 2018Multiple Sclerosis
Clinical Neurology NewsVIDEO: New MS ambulatory measure could fill clinical gapFebruary 3, 2018Multiple Sclerosis
Clinical Neurology NewsVIDEO: Alemtuzumab associated with long-term MS control in TOPAZ studyFebruary 3, 2018Multiple Sclerosis
Clinical Neurology NewsMS may be a transmissible protein misfolding disorder, study suggestsFebruary 2, 2018Multiple Sclerosis
Clinical Neurology NewsVIDEO: Could targeting gut dysbiosis in MS prevent disease?February 2, 2018Multiple Sclerosis
Clinical Neurology NewsRituximab fails to eliminate meningeal inflammation in progressive MSFebruary 1, 2018Multiple Sclerosis
Clinical Neurology NewsFingolimod cuts pediatric MS relapse rate more than interferon beta-1aFebruary 1, 2018Multiple Sclerosis
Clinical Neurology NewsStudy finds rising use of newer DMTs in pediatric-onset MSJanuary 31, 2018Multiple SclerosisPediatrics
Clinical Neurology NewsBarancik Prize winner to discuss MS biology advancesJanuary 26, 2018Multiple Sclerosis
Clinical Neurology NewsResearcher’s talk will tackle aging and gut bacteria in MSJanuary 26, 2018Multiple Sclerosis
Clinical Neurology NewsACTRIMS Forum 2018 highlights MS therapeutic targetsJanuary 26, 2018Multiple Sclerosis
Neurology ReviewsGeneric Glatiramer Acetate Remains Safe and Effective for Two YearsJanuary 17, 2018Multiple Sclerosis
